Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study record content and navigation with a generic error screen.SummaryDifference19%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new line 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' line was removed, indicating a minor update to the page's revision history.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a revision label updated from v3.6.4 to v3.6.5, indicating a minor platform update to the page. No substantive study content appears to be altered.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now displays Revision: v3.6.4, updating from Revision: v3.6.3. This indicates a site-wide version update and does not modify study content or results.SummaryDifference0.1%

- Check67 days agoChange DetectedNew update dates were added to the study record indicating the latest post on 2026-07-16 and a QC-approved update on 2026-06-25, while previous timestamps were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the prior v3.6.2. This update reflects a new entry version for the ClinicalTrials.gov page rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.